Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cambrex

Cambrex
1981 FOUNDED
PUBLIC STATUS
1K-5K EMPLOYEES
CBM STOCK SYMBOL
10 INVESTMENTS
$59.83 SHARE PRICE (As of Friday Closing)
Description

Cambrex Corp is a biotechnology company focused on developing and commercializing new and generic therapeutics. The company primarily supplies its products and services worldwide to innovator and generic pharmaceutical companies. Cambrex's portfolio growth strategy has a particular focus on the later stages of the clinical trial process. It also works to secure long-term supply agreements to produce active pharmaceutical ingredients and intermediates for newly approved drug products. Additionally, Cambrex sometimes works with partners to co-develop portfolios of niche generic drug products in a finished dosage form.

Formerly Known As
CasChem
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
NYS
Primary Office
  • One Meadowlands Plaza
  • East Rutherford, NJ 07073
  • United States

+1 (201) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cambrex’s full profile, request a free trial.

Cambrex Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$33.80 - $60.29 $2.02B $59.86 $1.10 449K 33.7M

Cambrex Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 2,488,994 1,495,093 1,454,921 1,643,771
Revenue 619,201 532,093 534,456 490,644
EBITDA 145,113 151,629 174,926 152,921
Net Income 36,785 92,418 102,450 81,678
Total Assets 1,506,560 1,223,428 740,565 611,865
Total Debt 528,613 300,000 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cambrex Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Cambrex‘s full profile, request access.

Request full access to PitchBook

Cambrex Competitors (33)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Catalent Formerly PE-Backed Somerset, NJ 00000 00.000 000000 - 000 00.000
000000000 00000000 Venture Capital-Backed Cork, Ireland 00 00.000 0000000000 00.000
00000000 Corporate Backed or Acquired Basel, Switzerland 000000 000000000000
000000000000000 Corporation Brentford, United Kingdom 000000 00000000000
000000000 Corporation Stockholm, Sweden 0000 00000 00000000 00000
To view this company’s complete list of competitors, request access »

Cambrex Acquisitions (10)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 02-Jan-2019 000000000000000000 00000 Drug Discovery 000000 00000 00
0000 0000000000000 12-Sep-2018 000000000000000000 00000 Drug Discovery 000000 00000 00
0000000 0000 00000 07-Oct-2016 000000000000000000 0000 Biotechnology 000000 00000 00
0000000 000000 03-Nov-2010 000000000000000000 0000 Drug Discovery 000000 00000 00
IEP 23-Mar-2010 Merger/Acquisition 00.000 Specialty Chemicals
To view this company’s complete investment and acquisition history, request access »

Cambrex Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 (000000 0 30-Oct-2001 000000000000000000 Completed
  • 0000000
To view this company’s complete exits history, request access »

Cambrex Subsidiaries (4)

Company Name Industry Location Founded
Avista Pharma Drug Discovery Durham, NC 2015
0000 0000000000000 Drug Discovery Whippany, NJ 0000
0000000 000000 Drug Discovery Hyderabad, India 0000
0000000 0000 00000 Biotechnology High Point, NC 0000
To view this company’s complete subsidiary history, request access »

Cambrex Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Cambrex‘s full profile, request access.

Request full access to PitchBook

Cambrex Executive Team (6)

Name Title Board
Seat
Contact
Info
Steven Klosk JD Chief Executive Officer & Board Member
Gregory Sargen Chief Financial Officer & Executive Vice President
Shawn Cavanagh Chief Operating Officer & Executive Vice President
Dorothy Donnelly-Brienza Chief Human Resources Officer and Senior Vice President

2 Former Executives

You’re viewing 4 of 6 executives. Get the full list »

Cambrex Board Members (4)

Name Representing Role Since Contact
Info
00000 00000000 Self Board Member 000 0000
00000 000000000 Self Board Member 000 0000
000000 00000 Self Chairman & Board Member 000 0000
000000 00000 00 Cambrex Chief Executive Officer & Board Member 000 0000